Published

Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Heliyon
Date: 2022-12-01
Source: PubMed
DOI: 10.1016/j.heliyon.2022.e12135
PubMed: 36536916

Authors

Kelmendi B Kichuk SA DePalmer G Maloney G Ching THW Belser A Pittenger C

Watch author

Derived topics and classifications

psilocybin OCD Receptor Pharmacology Emotional Processing Case Report Case Report

Citation graph

0 referenced DOIs found in stored source metadata. 5 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review2026-07-01 Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis2026-05-29 A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder2026-05-01 Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins2026-04-21 Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report.2022-12-01

Related papers

Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept StudyClinicalTrials.gov · 2026-03-11 Psilocybin for Treatment of Obsessive Compulsive DisorderClinicalTrials.gov · 2024-08-30 Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic EffectsClinicalTrials.gov · 2026-07-09